Obviousness

Obviousness Analysis of U.S. Patent 7,670,612 B2 under 35 U.S.C. § 103

This analysis evaluates whether the independent claims of U.S. Patent 7,670,612 B2 (the '612 patent) would have been obvious to a person having ordinary skill in the art (PHOSITA) at the time of the invention, based on the prior art cited during prosecution. A PHOSITA in this context is understood to be an individual with experience in pharmaceutical or nutritional supplement formulation and capsule manufacturing technology. The analysis is based on the combination of prior art references to arrive at the claimed invention.

---

Obviousness of Independent Claim 1

Claim 1 protects a hard-shell capsule with at least two chambers, containing two different ingredients (from the group of nutraceuticals, vitamins, dietary supplements, or minerals) in two different physical states, with at least one being for immediate release.

An argument for the obviousness of claim 1 can be constructed by combining the teachings of U.S. Patent 5,679,376 A ('376 patent) with the general knowledge of a PHOSITA regarding the formulation of nutritional supplements.

• Primary Reference: U.S. Patent 5,679,376 A
  The '376 patent explicitly discloses the core structure of the invention: a hard gelatin capsule with two separate chambers designed to hold two different substances. Critically, it teaches that these substances can be in different physical states, such as a powder in one chamber and a liquid, paste, or gel in the other (Column 2, lines 40-45). The '376 patent also states its utility for "pharmaceutical, cosmetic, dietetic or food products" (Column 1, lines 47-49). A standard hard gelatin capsule, as described, is inherently an immediate-release dosage form.

  Therefore, the '376 patent teaches every element of claim 1 except for the specific limitation that the ingredients must be selected from the group consisting of "a nutraceutical, a vitamin, a dietary supplement, and a mineral." While it does disclose "dietetic products," which overlaps with "dietary supplement," it does not explicitly teach the entire claimed group.

• Secondary Reference: General Knowledge of a PHOSITA
  As of the 2002 priority date, it was widely known in the art of nutritional science and supplement formulation that:

  1. Vitamins, minerals, and other nutraceuticals are often combined into single dosage forms.
  2. Certain ingredients are incompatible and can degrade one another when mixed. For example, minerals are known to accelerate the oxidation of certain vitamins.
  3. Different ingredients have optimal delivery forms for stability and bioavailability. Oil-soluble vitamins (e.g., Vitamin E) are best formulated in a liquid or gel, while bulky minerals (e.g., calcium carbonate) are most practically formulated as a solid powder.

• Motivation to Combine:
  A PHOSITA, faced with the common problem of formulating a combination supplement with incompatible ingredients or ingredients best delivered in different physical forms, would have been motivated to look for solutions. The '376 patent provides an explicit solution: a multi-chamber capsule designed specifically to separate incompatible substances or substances in different physical states.

  The motivation to combine the known ingredients (vitamins, minerals, etc.) with the known delivery apparatus (the '376 capsule) would have been to achieve a predictable result: a more stable and potentially more bioavailable combination supplement. Applying the technology of the '376 patent to the specific field of dietary supplements would have been an obvious application of a known tool to solve a known problem. The substitution of the '376 patent's general "dietetic products" with the more specific, well-known categories of vitamins and minerals would represent a simple, logical, and obvious design choice to a formulator in this field.

---

Obviousness of Independent Claim 58

Claim 58 is narrower than claim 1, specifically protecting a multi-compartment, hard-shell capsule containing at least one vitamin and at least one mineral in different physical states.

A similar argument for obviousness can be made by combining U.S. Patent 5,679,376 A (or, alternatively, U.S. Patents 6,294,192 B1 or 6,083,531 A) with the general knowledge of a PHOSITA.

• Primary Reference: U.S. Patent 5,679,376 A (or '192 or '531)
  As established above, these patents teach the fundamental structure: a multi-compartment hard-shell capsule for separating different ingredients in different physical states (e.g., solid and liquid) for immediate release. The '192 patent refers to "active ingredients," and the '531 patent refers to both "active ingredients" and "medicaments." None of them specifically name a vitamin/mineral combination.

• Secondary Reference: General Knowledge of a PHOSITA
  The formulation of combination multivitamin/multimineral products was a mature art by 2002. A skilled formulator would have been well-aware of the following:

  1. The desire to combine vitamins and minerals into a single pill for consumer convenience.
  2. The known chemical interactions between certain vitamins and minerals that compromise the stability and shelf-life of the final product.
  3. The benefits of formulating oil-soluble vitamins (e.g., A, D, E, K) in a liquid/oil-based matrix and formulating most minerals as solid powders or granules.

• Motivation to Combine:
  A PHOSITA tasked with creating an improved multivitamin/mineral product would be motivated to separate these ingredients to enhance stability and optimize delivery. The primary references ('376, '192, '531) disclose an apparatus explicitly designed for such separation.

  The motivation to place a vitamin in one chamber and a mineral in the other would have been to:

  • Improve Stability: Prevent the direct physical contact between, for example, an oxidizing mineral and a sensitive vitamin, thereby leading to a predictably longer shelf life.
  • Optimize Bioavailability: Deliver each component in its ideal physical state—a liquid carrier for an oil-soluble vitamin and a solid powder for a mineral—within a single dose, which would be expected to yield predictable improvements in absorption.

  Therefore, combining the known practice of co-formulating vitamins and minerals with the known capsule technology for separating ingredients in different physical states would have been obvious to a PHOSITA. It would be seen as the application of an existing solution to a well-known formulation challenge, with a high degree of expected success.